Clinical Associate Professor
827 Linden Avenue Second Floor
Education and Training
1999: B.A., History, Loyola College (Magna cum Laude) Baltimore, Maryland
2003: M.D., University of Maryland School of Medicine Baltimore, Maryland
2003-2006: Residency, Emory University School of Medicine, J. Willis Hurst Internal Medicine Residency Program
2006-2009: Fellowship, Endocrinology, Diabetes, and Metabolism, National Institutes of Health NIDDK-NICHD Inter-Institute Endocrine Training Program
Dr. Malek joined the University of Medicine School of Medicine in 2011. She is actively involved in medical education. She is the Course Director of Pathophysiology and Therapeutics II and the Program Director of the Endocrinology, Diabetes, and Metabolism Fellowship.
Dr. Malek sees patients at the University of Maryland Center for Diabetes and Endocrinology at the Midtown campus. Dr. Malek has extensive experience managing patients with both type 1 and 2 diabetes mellitus. She uses continuous glucose monitors and insulin pumps to manage complicated diabetes cases. She works as part of a multi-disciplinary team to improve the care of all her patients with diabetes. She has both clinical and research experience managing patients with extreme insulin resistance.
In her endocrine practice, Dr. Malek has a clinical interest in women's metabolic health, with a focus on management pre-diabetes, gestational diabetes, polycystic ovarian syndrome, and congenital adrenal hyperplasia. She is currently involved in research to increase access to care and appropriate medical follow up for women with a history of gestational diabetes.
New patients can call 443-682-6800 to schedule appointments.
Pathophysiology, Therapeutics, Endocrinology, Diabetes, Metabolism
Malek R, Chong AY, Lupsa BC, Lungu AO, Cochran EK, Soos MA, Semple RK, Balow JE, Gorden P. Treatment of type B insulin resistance: A novel approach to reduce insulin receptor auto-antibodies. J Clin Endocrinol Metab 2010; 95(8) 3641-3647.
Malek R, Davis SN. Novel methods of insulin replacement: The artificial pancreas and encapsulated islets. Rev Recent Clin Trials. 2016;11(2):106-23
Malek R, Davis SN. Tyrosine kinase inhibitors under investigation for the treatment of type 2 diabetes. Expert Opin Investig Drugs. 2016 Mar;25(3):287-96.
Malek R, Davis SN. Pharmacokinetics, efficacy, and safety of glyburide for treatment of gestational diabetes. Expert Opin Drug Metab Toxicol. 2016 May 23:1-9.
Subang ML, Konig M, Staats PN, Lamos EM, Munir KM, Malek R. Third trimester intraplacental choriocarcinoma presenting with respiratory failure and hyperthyroidism. AACE Clinical Case Rep. 2016;2(No. 3)